Genmab A/SGNMSF
13F holders, Q3 2024 (September 30)1holders
0new positions
0sold out
$242.00avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Genmab A/S (GNMSF) in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holder was Williams Jones Wealth Management, LLC. ($209K).
- Company
- Genmab A/S
- CUSIP
- K3967W102
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 16,314 shares sold, net −16,314 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Williams Jones Wealth Management, LLC. | 0.00% | Reduce -95.0% | 862 | $209K |
"% of holder's portfolio" is GNMSF's weight in each manager's 13F, not the share of Genmab A/S the manager owns.